Abstract
Objectives
To compare the diagnostic performance of ultrasound, contrast-enhanced computed tomography (CT) and 18F-FDG positron emission tomography (PET)/CT for detecting recurrent differentiated thyroid cancer in the neck.
Methods
Twenty patients who had undergone previous surgery for differentiated thyroid cancer (19 papillary carcinomas; 1 medullary carcinoma) and presented with pathologically proven recurrence in the neck were included. All patients had undergone ultrasound, CT and PET/CT in the 2 months before further surgery. In each patient, ultrasound, CT and PET/CT images were retrospectively reviewed to determine the presence of loco-regional recurrence by level-by-level analysis. Imaging results were correlated with the histological evaluation of the neck dissection as a standard of reference.
Results
Recurrences were found at 52 out of 110 cervical nodal levels surgically explored. The sensitivity, specificity and accuracy were 69.2 %, 89.7 % and 80.0 % for ultrasound; 63.5 %, 94.8 % and 80.0 % for CT; and 53.8 %, 79.3 % and 67.3 % for PET/CT, respectively. ROC analysis revealed higher diagnostic performance with ultrasound than with PET/CT for detecting recurrent tumour.
Conclusions
Although no significant difference was found among the three techniques, the sensitivity and specificity of ultrasound and CT were higher than those of PET/CT for the evaluation of cervical recurrence in patients with differentiated thyroid cancer.
Key Points
• Ultrasound, CT and 18 F-FDG PET/CT can all detect recurrent thyroid cancer.
• Ultrasound and CT have higher sensitivity and specificity.
• Ultrasound, CT and 18 F-FDG PET/CT frequently demonstrated discordant findings
Similar content being viewed by others
References
Johnson NA, Tublin ME (2008) Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies. Radiology 249:429–444
Aygun N (2008) Imaging of recurrent thyroid cancer. Otolaryngol Clin North Am 41:1095–1106
Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428
Lee JH, Lee HK, Lee DH et al (2007) Ultrasonographic findings of a newly detected nodule on the thyroid bed in postoperative patients for thyroid carcinoma: correlation with the results of ultrasonography-guided fine-needle aspiration biopsy. Clin Imaging 31:109–113
Vassallo P, Wernecke K, Roos N, Peters PE (1992) Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 183:215–220
Rosário PW, de Faria S, Bicalho L et al (2005) Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. J Ultrasound Med 24:1385–1389
Sakai O, Curtin HD, Romo LV, Som PM (2000) Lymph node pathology: benign proliferative, lymphoma, and metastatic disease. Radiol Clin North Am 38:979–998
Som PM, Brandwein M, Lidov M, Lawson W, Biller HF (1994) The varied presentations of papillary thyroid carcinoma cervical nodal disease: CT and MR findings. Am J Neuroradiol 15:1123–1128
van den Brekel MW, Stel HV, Castelijns JA et al (1990) Cervical lymph node metastasis: assessment of radiological criteria. Radiology 177:379–384
Nygaard B, Nygaard T, Jensen LI et al (1998) Iohexol: effects on uptake of radioactive iodine in the thyroid and on thyroid function. Acad Radiol 5:409–414
Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H (1997) Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 24:1342–1348
Jeong HS, Baek CH, Son YI et al (2006) Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT. Clin Endocrinol (Oxf) 65:402–407
Haerle SK, Strobel K, Ahmad N, Soltermann A, Schmid DT, Stoeckli SJ (2011) Contrast-enhanced 18F-FDG-PET/CT for the assessment of necrotic lymph node metastases. Head Neck 33:324–329
Nakagawa T, Yamada M, Suzuki Y (2008) 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med 49:1053–1059
Altenvoerde G, Lerch H, Kuwert T, Matheja P, Schäfers M, Schober O (1998) Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans. Langenbecks Arch Surg 383:160–163
Grünwald F, Schomburg A, Bender H et al (1996) Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 23:312–319
Mazzaferri EL, Robbins RJ, Spencer CA et al (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433–1441
Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142
Sherman SI, Tielens ET, Sostre S, Wharam MD Jr, Ladenson PW (1994) Clinical utility of post treatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 78:629–634
Lee DH, Kang WJ, Seo HS et al (2009) Detection of metastatic cervical lymph nodes in recurrent papillary thyroid carcinoma: computed tomography versus positron emission tomography-computed tomography. J Comput Assist Tomogr 33:805–810
Choi JW, Lee JH, Baek JH et al (2010) Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma. Ultrasound Med Biol 36:1608–1615
Som PM, Curtin HD, Mancuso AA (2000) Imaging-based nodal classification for evaluation of neck metastatic adenopathy. Am J Roentgenol 174:837–844
Kuna SK, Bracic I, Tesic V, Kuna K, Herceg GH, Dodig D (2006) Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 25:1531–1537
Kim E, Park JS, Son KR, Kim JH, Jeon SJ, Na DG (2008) Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid 18:411–418
Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W (1996) Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37:1468–1472
Ferris RL, Branstetter BF, Nayak JV (2005) Diagnostic utility of positron emission tomography-computed tomography for predicting malignancy in cystic neck masses in adults. Laryngoscope 115:1979–1982
Crippa F, Leutner M, Belli F et al (2000) Which kinds of lymph node metastases can FDG PET detect? a clinical study in melanoma. J Nucl Med 41:1491–1494
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18 fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972–1980
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seo, Y.L., Yoon, D.Y., Baek, S. et al. Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and 18F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. 18F-FDG PET/CT in recurrent thyroid cancer). Eur Radiol 22, 2246–2254 (2012). https://doi.org/10.1007/s00330-012-2470-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-012-2470-x